Riskpilot← Back to searchSign inGet full accessMedimore AB
ABActiveOrg 5566886254Eriksvägen 21Medical specialists activities · NACE 8622Est. 20052 employees
Revenue 2025
SEK 2,2M
-2% vs 2024
EBITDA margin
14.3%
-48% vs 2024
Equity ratio
78.1%
Financial strength
Net profit 2025
SEK 236K
-55% vs 2024
| Revenue | SEK 2,2M | -2% |
| EBITDA | SEK 313K | -48% |
| Net profit | SEK 236K | -55% |
| Total assets | SEK 969K | -13% |
| Equity | SEK 757K | +5% |
| Employees | 2 | — |
Legal name
Medimore AB
Org number
5566886254
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
25 oktober 2005
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Medicinsk och kulturell utbildning, konsult och arbete samt därmed förenlig verksamhet.
Address
Eriksvägen 21
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 2 236 | 2 194 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −18 | −59 | −97 | 604 | 313 |
| Depreciation & amort. | −0 | −0 | −0 | −14 | −14 |
| EBIT | −18 | −59 | −97 | 590 | 299 |
| Net financials | — | — | −4 | −1 | — |
| Profit before tax | −18 | −59 | −98 | 591 | 298 |
| Tax | −0 | −55 | −0 | −72 | −62 |
| Net profit | −18 | −114 | −98 | 519 | 236 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 415 | 301 | 203 | 1 118 | 969 |
| Equity | 415 | 301 | 203 | 721 | 757 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 397 | 212 |
| Total debt | — | — | — | 397 | 212 |
EBITDA margin
14.3%
This company
15.8%
Market median
-9% vs market
20212025
Equity ratio
78.1%
This company
38.2%
Market median
+104% vs market
20212025
Return on equity
31.2%
This company
18.4%
Market median
+70% vs market
20212025
Net profit margin
10.8%
This company
8.1%
Market median
+33% vs market
20212025
Asset turnover
2.26×
This company
1.12×
Market median
+102% vs market
20212025
Debt / equity
0.28×
This company
0.62×
Market median
+55% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HG Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Medimore AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Gunnar Holgert | Chief Executive Officer | 0 companies |
| Angelika Martina Otto Holgert | Deputy Board Member | 0 companies |